eye drops delay, will prevent, myopia

Published Date: 16 Feb 2023

Researchers have found that dilating eye drops that children use daily can delay the onset of myopia.

Read Full News

Latest News

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

What Caused Visual Disturbance in Kidney Transplant Patient?

Genetic testing identified PAX2 gene variant

Floaters Affect Vision of Kidney Transplant Patient

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Todays Updates

A Sinister Etiology for Shoulder Pain

Patient presented with what was assumed to be rotator cuff injury

Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx

Consistently low PSA levels failed to signal metastasis

Study Hints at Survival Benefit With Transplant for Metastatic Lung Cancer

— Substantially longer 1-year survival observed in rare subset of patients with lung-only disease

Latest News

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

Genetic testing identified PAX2 gene variant

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

News All Time

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Aligned: Patient Selection and Counseling for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Focus Reengineered: Mechanisms and Clinical Data for Pharmacologic Presbyopia Therapies

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Mock P&T: Applying the Latest Evidence to Advance Managed Care Decision-Making in Retinal Vascular Disease

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

Precision Ocular Care: Integrating Oncology and Eyecare to Conquer Cancer Therapy-Related Toxicities

AAO: American Academy of Ophthalmology

ASRS: American Society of Retina Specialists

ARVO Video Pearls: Video Pearls From The Association for Research in Vision and Ophthalmology

AAO Video Pearls: Video Pearls from the American Academy of Ophthalmology

ARVO: Association for Research in Vision and Ophthalmology

Trump Showing His Age? Nasal Spray Recalled; Elton John on Losing Sight

Health news and commentary gathered by MedPage Today staff

Pay Cuts and Unnecessary Visits: How Medicare Is Compromising Cataract Care

It's time for payment reform and a lasting remote follow-up option

Higher-Dose Aflibercept Similar to Standard Dose in Severe AMD Variant

Patients with PCV gain standard-dose benefits, with less-frequent dosing

One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk

But it's not time to prescribe tirzepatide outside current indications, expert says

Cardiovascular Risk Score Shows Value in Predicting Future Eye Disease

The score is commonly calculated in primary care

Contaminated Water Blamed for 10 Deaths; FDA Rejections; Mammograms for Heart Risks?

Health news and commentary gathered by MedPage Today staff

Color Blindness and Bladder Cancer: A Bad Combination for Survival?

Study suggests inability to identify blood in urine may delay diagnosis and reduce survival

Recommended News For You

Do I qualify for a cancer clinical trial?

Can Oncotype Predict Recurrence Risk in Older BC Patients?

For the treatment of vestibular schwannomas in neurofibromatosis type 2, stereotactic radiosurgery has been found to be effective.

LAIs vs Oral Antipsychotics for Bipolar I Rehospitalization

Canine Cancer Vaccine: A Potential Resurrection? U.S. KK. Snubs Enertu.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

Recommended Articles For You

Unlocking the Potential of Trabectedin: A Novel Therapy for Cancer Treatment 

Emerging Frameworks in Oncology in Clinical Decision-Making 

The Millionaire's Battle: Does Mark Cuban Have Cancer? 

Introduction to Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

CAR-T for Chronic Lymphocytic Leukemia Receives FDA Approval.

2.

Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients

3.

PSA Screening May Modestly Curb Prostate Cancer Deaths

4.

Extended lymphadenectomy has no survival benefit in patients with muscle-invasive bladder cancer.

5.

Can Children With Low-Risk Hodgkin Lymphoma Skip Radiation?

1.

Exploring New Treatment Options for Hemophilia: A Journey into the Unknown

2.

Understanding Mean Corpuscular Volume: A Comprehensive Guide 

3.

Unlocking the Potential of Ferrotonia: A New Way to Harness Magnetic Energy

4.

Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management

5.

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot